Home » Topics » BioWorld Science

BioWorld Science
RSS

EMA validates application for Cabometyx for previously treated advanced HCC

March 28, 2018

Semglee biosimilar insulin glargine approved in E.U. and Australia

March 28, 2018

FDA advisory committee recommends approval of Lucemyra

March 28, 2018

Carna Biosciences enters joint research agreement with Sumitomo Dainippon Pharma

March 28, 2018

AnaptysBio reports encouraging topline proof-of-concept data for ANB-020 in peanut allergy

March 28, 2018

Bardoxolone methyl granted Sakigake designation in Japan

March 28, 2018

Altimmune updates NasoVAX and HepTcell programs

March 28, 2018

KIFC1 a potentially new and druggable target for colorectal carcinoma

March 28, 2018

Japanese Sakigake designation granted to cancer programs

March 28, 2018

Aurigene Discovery Technologies presents novel VISTA protein inhibitors

March 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...